- Home
- ATLO vs INBX Comparison
ATLO vs INBX Comparison
Compare ATLO & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATLO
- INBX
- Stock Information
- Founded
- ATLO 1903
- INBX 2010
- Country
- ATLO United States
- INBX United States
- Employees
- ATLO N/A
- INBX N/A
- Industry
- ATLO Major Banks
- INBX Biotechnology: Pharmaceutical Preparations
- Sector
- ATLO Finance
- INBX Health Care
- Exchange
- ATLO Nasdaq
- INBX Nasdaq
- Market Cap
- ATLO 177.0M
- INBX 345.8M
- IPO Year
- ATLO N/A
- INBX 2020
- Fundamental
- Price
- ATLO $20.40
- INBX $26.71
- Analyst Decision
- ATLO
- INBX Hold
- Analyst Count
- ATLO 0
- INBX 2
- Target Price
- ATLO N/A
- INBX N/A
- AVG Volume (30 Days)
- ATLO 10.1K
- INBX 111.3K
- Earning Date
- ATLO 11-07-2025
- INBX 11-13-2025
- Dividend Yield
- ATLO 3.89%
- INBX N/A
- EPS Growth
- ATLO 43.95
- INBX N/A
- EPS
- ATLO 1.53
- INBX N/A
- Revenue
- ATLO $57,731,000.00
- INBX $1,400,000.00
- Revenue This Year
- ATLO N/A
- INBX N/A
- Revenue Next Year
- ATLO N/A
- INBX N/A
- P/E Ratio
- ATLO $13.41
- INBX N/A
- Revenue Growth
- ATLO 12.59
- INBX N/A
- 52 Week Low
- ATLO $15.69
- INBX $10.81
- 52 Week High
- ATLO $20.75
- INBX $30.23
- Technical
- Relative Strength Index (RSI)
- ATLO 62.83
- INBX 54.46
- Support Level
- ATLO $20.00
- INBX $27.51
- Resistance Level
- ATLO $20.72
- INBX $28.86
- Average True Range (ATR)
- ATLO 0.35
- INBX 1.44
- MACD
- ATLO 0.01
- INBX -0.28
- Stochastic Oscillator
- ATLO 69.57
- INBX 31.85
About ATLO Ames National Corporation
Ames National Corporation is a United States-based bank holding company. It provides short-term and medium-term commercial, multi-family, and agricultural real estate loans, residential real estate loans, agricultural and business operating loans and lines of credit, equipment loans, vehicle loans, personal loans and lines of credit, home improvement loans and origination of mortgage loans for sale into the secondary market. The Banks also offer a variety of checking, savings and time deposits, cash management services, merchant credit card processing, safe deposit boxes, wire transfers, direct deposit and automated/video teller machine access. The banking segment generates revenues through personal, business, agricultural and commercial lending, and Others.
About INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.